title: Testis specific gene expression drives disease progression and Rituximab resistance in lymphoma.
authors.affiliation: Nuffield Department of Clinical Medicine, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), University of Oxford, Oxford, UK. stefan.knapp@sgc.ox.ac.uk
authors.forename: Stefan
authors.initials: S
authors.lastname: Knapp
mesh_terms: D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D053263:Gene Regulatory Networks; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000378:metabolism*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab
keywords: BET proteins; Cyclon; JQ1; Rituximab; bromodomains
references.citation: Cell. 2011 Sep 16;146(6):904-17
references.pmid: 21889194
references.citation: Nat Rev Cancer. 2005 Aug;5(8):615-25
references.pmid: 16034368
references.citation: Curr Opin Oncol. 2012 Sep;24(5):461-5
references.pmid: 22759738
references.citation: Sci Transl Med. 2013 May 22;5(186):186ra66
references.pmid: 23698379
references.citation: Nature. 2010 Dec 23;468(7327):1067-73
references.pmid: 20871596
references.citation: EMBO Mol Med. 2013 Aug;5(8):1180-95
references.pmid: 23828858
references.citation: N Engl J Med. 2008 Aug 7;359(6):613-26
references.pmid: 18687642
references.citation: FEBS Lett. 2007 Mar 6;581(5):975-80
references.pmid: 17300783
references.citation: Annu Rev Pathol. 2012;7:247-65
references.pmid: 22017582
references.citation: Oncology (Williston Park). 2012 May;26(5):488-95
references.pmid: 22730604
references.citation: EMBO J. 2012 Oct 3;31(19):3809-20
references.pmid: 22922464